Zampilimab
Zampilimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Zampilimab is under investigation in clinical trial NCT04335578 (A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of UCB7858 in Adult Kidney Transplant Recipients With Chronic Allograft Injury).
| Trade Name | Zampilimab |
| Generic | Zampilimab |
| Zampilimab Other Names | Zampilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Zampilimab
